Zobrazeno 21 - 30
of 2 606
pro vyhledávání: '"35"'
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 56:440-443
Purpose: This retrospective study evaluated data pertaining to the history, symptoms, treatment, and prognosis of a series of patients treated for acinic cell carcinoma (ACC). Patients and Methods: Data were based on the records of 35 patients. Follo
Autor:
M Quinzanini, Franco Franceschini, Ilaria Cavazzana, C Vassalini, Paolo Airò, Roberto Cattaneo, E Danieli
Publikováno v:
Lupus. 14(10)
The objective of this study was to analyse clinical and serological associations of anti-Ki antibodies. Thirty-five patients with anti-Ki antibodies, detected by CIE, selected from laboratory routine, were studied. All patients were affected by autoi
Autor:
Lei Ji, Gui-Juan Ji, Shu-yang Zhu, Yu-Ying Gan, Wenhui Zhang, Jun He, Ping-li Liu, Yanan Liu, Bi Chen
Publikováno v:
Journal of Clinical Laboratory Analysis
Background Systemic inflammation has a critical role in the pathogenesis of obstructive sleep apnea (OSA). Interleukin (IL)‐35 and IL‐37 have been identified as novel immune‐modulating cytokines with anti‐inflammatory activities in numerous t
Autor:
Daniela Šošo, Esma Čečuk Jeličić, Jure Aljinović, Sanja Lovrić Kojundžić, Daniela Marasović Krstulović, Ivanka Marinović
Publikováno v:
Clinical rheumatology. 39(8)
To investigate possible association between sacroiliitis and HLA-B*35 positivity.After excluding patients with axial spondyloarthritis and HLA-B*27 positivity, psoriasis inflammatory bowel disease, preceding infections, or juvenile type of spondyloar
Autor:
Tsukasa Ikeura, Takashi Tomiyama, Takashi Ito, Toshiro Fukui, Takashi Yamaguchi, Kazuichi Okazaki, Toshihiro Tanaka, Akiyoshi Nishio, Yugo Ando, Koh Nakamaru, Kazushige Uchida
Publikováno v:
Journal of Gastroenterology. 55:789-799
IgG4-related disease (IgG4-RD) is a systemic inflammatory disease, which includes type 1 autoimmune pancreatitis (AIP). Interleukin-35 (IL-35) exhibits immunosuppressive effects in several autoimmune diseases. However, the expression of IL-35 had not
Autor:
Yangtai Guan, Lu Han, Yong Hao, Yun‐Jia Zhou, Xia-Feng Shen, Hong Yang, Yu Cai, Jie Ding, Rong-Hua Hong, Desheng Zhu
Publikováno v:
CNS Neuroscience & Therapeutics
Aims The exact pathogenesis of neuromyelitis optica spectrum disorder (NMOSD) remains unclear. A variety of cytokines are involved, but few studies have been performed to explore the novel roles of interleukin‐22 (IL‐22) and interleukin‐35 (IL
Publikováno v:
Rheumatology International. 38:1511-1519
The aim of the study is to investigate the levels of serum interleukin-35 (IL-35) before and after treatment and its relationship with clinical parameters as well as the frequency of different subsets of CD4+ T cells in patients with systemic scleros
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 38(10)
Interleukin-35 (IL-35) is a critical anti-inflammatory cytokine in autoimmune disease. In the current study, we aimed to investigate the serum IL-35 levels and its clinical association in patients with primary Sjögren's syndrome (pSS) and to investi
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Shenghua Jiang,1,2 Fenglian Shan,2 Youwen Zhang,1,2 Luning Jiang,2 Zhaozhong Cheng1 1Department of Respiratory Medicine, Affiliated Hospital, Qingdao University, Qingdao, China; 2Department of Respiratory Medicine, Affiliated Hospital of Jining Medic
Publikováno v:
The Tohoku journal of experimental medicine. 244(4)
Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease with a wide range of clinical presentations. Lupus nephritis (LN) is the most serious manifestation of SLE. Interleukin-35 (IL-35), a member of the interleukin-12 family, h